Pricing Log in Create free account
Saturday 17 October 2026 Export GEHC’s income statement to Excel — free account

GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

GE HealthCare Technologies Inc. (GEHC) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, GE HealthCare Technologies Inc. (GEHC) trades at a EV/Sales of 1.9×. Over the past ten years it has ranged from 0.0× (December 2022) to 2.6× (March 2024); the current reading is higher than 14% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (1.70%)
FY2024 2.2× (0.54%)
FY2023 2.2× 25.75%
FY2022 1.8× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.8× (9.16%)
Mar 2026 2.0× (7.94%)
Dec 2025 2.2× 4.04%
Sep 2025 2.1× (0.63%)
14 more quarters

Against its own ten years

Low 0.0× High 2.6×
Ten-year median 2.2×
Current reading's percentile 13

EV/Sales against peers

Company EV/Sales
PHG Koninklijke Philips N.V. compare 1.4×
SNN Smith & Nephew SNATS, Inc. compare 1.5×
GEHC GE HealthCare Technologies Inc. 1.9×
ZBH Zimmer Biomet Holdings, Inc. compare 3.0×
BSX Boston Scientific Corporation compare 3.7×
STE STERIS plc compare 3.8×
DXCM DexCom, Inc. compare 6.6×
EW Edwards Lifesciences Corporation compare 7.2×
PEN Penumbra, Inc. compare 8.0×
Medical Devices industry median 2.2×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on GEHC